34 MAPLE ST, MILFORD, MA
Waters Corporation Completes $3.5 Billion Senior Notes Offering
Other Events
Reports Fourth Quarter and Full-Year 2025 Financial Results
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
Shareholders Approve Combination with BD’s Biosciences & Diagnostic Solutions Business
Investor Presentation
Reports Third Quarter 2025 Financial Results
FY 2024
Q3
Q2
Q1
FY 2023
Prospectus Filed Pursuant to Rule 424(b)(2)
S-3ASR
Registration Statement for Securities to be Offered to Employees
Prospectus Filed Pursuant to Rule 425
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Free Writing Prospectus
Specialized Disclosure Report